BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11166856)

  • 1. The treatment of rhinovirus infections: progress and potential.
    Turner RB
    Antiviral Res; 2001 Jan; 49(1):1-14. PubMed ID: 11166856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on influenza and rhinovirus infections.
    Hayden FG
    Adv Exp Med Biol; 1999; 458():55-67. PubMed ID: 10549379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rhinovirus diseases: pathogenesis, diagnostics and treatment].
    Faĭzuloev EB; Nikonova AA; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):115-21. PubMed ID: 16279553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the treatment of rhinovirus infections.
    McKinlay MA
    Curr Opin Pharmacol; 2001 Oct; 1(5):477-81. PubMed ID: 11764773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy for enteroviruses and rhinoviruses.
    Rotbart HA
    Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in rhinovirus therapeutics.
    Charles CH; Yelmene M; Luo GX
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
    Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
    Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common cold.
    Arroll B
    Clin Evid; 2006 Jun; (15):2006-14. PubMed ID: 16973075
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy evaluation of pleconaril for treatment of the common cold.
    Fleischer R; Laessig K
    Clin Infect Dis; 2003 Dec; 37(12):1722. PubMed ID: 14689362
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
    Choi HJ; Song JH; Lim CH; Baek SH; Kwon DH
    J Med Food; 2010 Apr; 13(2):326-8. PubMed ID: 20412019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment.
    McKinlay MA; Pevear DC; Rossmann MG
    Annu Rev Microbiol; 1992; 46():635-54. PubMed ID: 1332585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.
    Patick AK; Binford SL; Brothers MA; Jackson RL; Ford CE; Diem MD; Maldonado F; Dragovich PS; Zhou R; Prins TJ; Fuhrman SA; Meador JW; Zalman LS; Matthews DA; Worland ST
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2444-50. PubMed ID: 10508022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targets in rhinoviral infections.
    Rohde G
    Infect Disord Drug Targets; 2009 Apr; 9(2):126-32. PubMed ID: 19275701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.
    Zalman LS; Brothers MA; Dragovich PS; Zhou R; Prins TJ; Worland ST; Patick AK
    Antimicrob Agents Chemother; 2000 May; 44(5):1236-41. PubMed ID: 10770757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
    Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.
    Fang F; Yu M
    J Antimicrob Chemother; 2004 Jan; 53(1):23-5. PubMed ID: 14657090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinacea angustifolia in rhinovirus infections.
    Leach M
    N Engl J Med; 2005 Nov; 353(18):1971-2; author reply 1971-2. PubMed ID: 16270425
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteases of human rhinovirus: role in infection.
    Jensen LM; Walker EJ; Jans DA; Ghildyal R
    Methods Mol Biol; 2015; 1221():129-41. PubMed ID: 25261311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffectiveness of echinacea for prevention of experimental rhinovirus colds.
    Turner RB; Riker DK; Gangemi JD
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1708-9. PubMed ID: 10817735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.